News
NEWS
-
financingCelaid raised an additional 140 million yen from Kobe University Capital and Techno Science
-
R&DCelaid Therapeutics Inc. Secures up to $19M Grant from the Japanese Agency for Medical Research and Development
-
newsCelaid will be Speaking at the “Umbilical Cord Blood Regenerative Medicine Study Group Academic Meeting”
-
newsCelaid will be exhibiting at and speaking at “Regenerative Medicine Japan 2024”
-
R&D
Tokyo Medical and Dental University and Celaid Therapeutics Inc. Joint Research Agreement on Research and Development of Gene-modified Cell Thera…
-
newsCelaid Therapeutics Inc has been selected for the Silicon Valley Immersion Program sponsored by NEDO
-
newsSpeaker at Biopharmaceutical EXPO
-
financing
Celaid has raised 1.2 billion yen in its Series A financing round to advance HSC-based cell and gene therapies and platform
-
R&D
FBRI and Celaid have executed a collaborative research agreement for vascular regeneration products derived from human hematopoietic stem cells